Market Overview:
The global cardiac tamponade market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The market growth is attributed to the increasing incidence of cardiac tamponade, rising demand for minimally invasive procedures, and technological advancements in the field of cardiac tamponade diagnosis and treatment. Based on type, the global cardiac tamponade market is segmented into X-ray, computed tomography (CT), magnetic resonance imaging (MRI), coronary angiography, electrocardiogram (EKG), and others. The MRI segment is expected to grow at the highest CAGR during the forecast period owing to its ability to provide high-resolution images that help in accurate diagnosis of heart diseases. Based on application, the global cardiac tamponade market is segmented into hospitals, clinics, cardiology centers/clinics/labs., academic institutes & research institutes and others. The hospitals segment accounted for majority share of the global Cardiac Tamponades Market in 2017 and it is projected to maintain its dominance during forecast period as well due rising prevalence of heart diseases across globe coupled with growing number diagnostic & treatment centers globally . However ,the clinics are projected witness highest growth rate over next decade due increase preference by patients for outpatient care settings over hospitalization setting . Region wise , North America commanded largest share followed by Europe in 2017 .
Product Definition:
A cardiac tamponade is a medical emergency in which fluid accumulates rapidly in the pericardial space, leading to compression of the heart. The most common cause is trauma, but it can also be caused by infection, cancer or other diseases. Symptoms include shortness of breath and chest pain. If left untreated, cardiac tamponade can lead to death. Cardiac tamponade is a life-threatening condition that requires immediate treatment.
X-Ray:
X-ray is a kind of electromagnetic ionizing radiation and it helps in visualization of the internal body structures. It is mainly used for diagnosis of broken bones, pneumonia, infections to name a few. In cardiac tamponade, X-ray can be used to look for accumulation of fluid in the heart (cardiac effusion). This test also helps in determining whether there are any other medical conditions along with cardiac tamponade such as kidney or liver failure or bowel disease etc.
Computed Tomography (CT):
Computed tomography is a diagnostic medical procedure that utilizes X-rays to obtain detailed information about the structure of various parts of the body. In cardiac computed tomography, this method is used for visualizing and analyzing heart valves, coronary arteries & veins, and other structures in order to diagnose & treat cardiac problems.
Application Insights:
The market is segmented into hospitals, clinics, cardiac centers, academic institutes and research institutes. Hospitals held the largest share in 2017 owing to the presence of key players such as Medtronic Plc., Boston Scientific Corporation., and Cordis Corporation. These players have developed a number of products for diagnosing conditions such as heart attack or stroke through invasive procedures that require an admission in hospital. This has led to an increase in demand for these products leading to growth at a faster rate than other segments during the forecast period.
Cardiac centers are expected to witness lucrative growth over the forecast period due to increasing awareness among patients regarding treatment options, technological advancements and government initiatives that support R&D pertaining to cardiovascular diseases (CVDs).
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of well-established healthcare infrastructure, high adoption rate of advanced technologies, and availability of highly skilled physicians in this region. Moreover, increasing prevalence of cardiac disorders is expected to drive the demand for tamponade products during the forecast period. According to a study published by Journal Of The American College Of Cardiology In 2015, it was stated that approximately 695,000 people died due to coronary heart diseases in U.S., which constituted nearly 40% deaths due to cardiovascular causes.
Asia Pacific is expected witness lucrative growth over a projected period owing its rapidly developing medical sector and rising patient awareness regarding available treatments for various cardiac disorders such as congestive heart failure (CHF), arrhythmias & palpitations etc’some time ago'.
Growth Factors:
- Increasing incidence of cardiac tamponade
- Rising awareness about the condition and its symptoms
- Growing number of surgical procedures for treating cardiac tamponade
- Availability of advanced diagnostic and treatment options
- increasing prevalence of cardiovascular diseases
Scope Of The Report
Report Attributes
Report Details
Report Title
Cardiac Tamponade Market Research Report
By Type
X-Ray, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Coronary Angiography, Electrocardiogram (EKG), Others.
By Application
Hospitals, Clinics, Cardiac Centers, Academic Institutes, Research Institutes, Others
By Companies
Boston Scientific Corporation, Medtronic, Abbott, Hitachi, Ltd., Koninklijke Philips N.V., Siemens AG, Cardio Vascular Services, General Electric, Edwards Lifesciences Corporation, Summit Medical Group, Clinical Care Options, LLC., High Impact Incorporated, Epic Medical Concepts & Innovations
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
209
Number of Tables & Figures
147
Customization Available
Yes, the report can be customized as per your need.
Global Cardiac Tamponade Market Report Segments:
The global Cardiac Tamponade market is segmented on the basis of:
Types
X-Ray, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Coronary Angiography, Electrocardiogram (EKG), Others.
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Cardiac Centers, Academic Institutes, Research Institutes, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Boston Scientific Corporation
- Medtronic
- Abbott
- Hitachi, Ltd.
- Koninklijke Philips N.V.
- Siemens AG
- Cardio Vascular Services
- General Electric
- Edwards Lifesciences Corporation
- Summit Medical Group
- Clinical Care Options, LLC.
- High Impact Incorporated
- Epic Medical Concepts & Innovations
Highlights of The Cardiac Tamponade Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- X-Ray
- Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
- Coronary Angiography
- Electrocardiogram (EKG)
- Others.
- By Application:
- Hospitals
- Clinics
- Cardiac Centers
- Academic Institutes
- Research Institutes
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cardiac Tamponade Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cardiac tamponade is a medical emergency that occurs when blood accumulates in the heart or lungs. The pressure from the blood can cause damage to these organs, leading to death.
Some of the key players operating in the cardiac tamponade market are Boston Scientific Corporation, Medtronic, Abbott, Hitachi, Ltd., Koninklijke Philips N.V., Siemens AG, Cardio Vascular Services, General Electric, Edwards Lifesciences Corporation, Summit Medical Group, Clinical Care Options, LLC., High Impact Incorporated, Epic Medical Concepts & Innovations.
The cardiac tamponade market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cardiac Tamponade Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cardiac Tamponade Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cardiac Tamponade Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cardiac Tamponade Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cardiac Tamponade Market Size & Forecast, 2018-2028
4.5.1 Cardiac Tamponade Market Size and Y-o-Y Growth
4.5.2 Cardiac Tamponade Market Absolute $ Opportunity
Chapter 5 Global Cardiac Tamponade Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Cardiac Tamponade Market Size Forecast by Type
5.2.1 X-Ray
5.2.2 Computed Tomography (CT)
5.2.3 Magnetic Resonance Imaging (MRI)
5.2.4 Coronary Angiography
5.2.5 Electrocardiogram (EKG)
5.2.6 Others.
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Cardiac Tamponade Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Cardiac Tamponade Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Cardiac Centers
6.2.4 Academic Institutes
6.2.5 Research Institutes
6.2.6 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cardiac Tamponade Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cardiac Tamponade Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Cardiac Tamponade Analysis and Forecast
9.1 Introduction
9.2 North America Cardiac Tamponade Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Cardiac Tamponade Market Size Forecast by Type
9.6.1 X-Ray
9.6.2 Computed Tomography (CT)
9.6.3 Magnetic Resonance Imaging (MRI)
9.6.4 Coronary Angiography
9.6.5 Electrocardiogram (EKG)
9.6.6 Others.
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Cardiac Tamponade Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Cardiac Centers
9.10.4 Academic Institutes
9.10.5 Research Institutes
9.10.6 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Cardiac Tamponade Analysis and Forecast
10.1 Introduction
10.2 Europe Cardiac Tamponade Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Cardiac Tamponade Market Size Forecast by Type
10.6.1 X-Ray
10.6.2 Computed Tomography (CT)
10.6.3 Magnetic Resonance Imaging (MRI)
10.6.4 Coronary Angiography
10.6.5 Electrocardiogram (EKG)
10.6.6 Others.
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Cardiac Tamponade Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Cardiac Centers
10.10.4 Academic Institutes
10.10.5 Research Institutes
10.10.6 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Cardiac Tamponade Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Cardiac Tamponade Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Cardiac Tamponade Market Size Forecast by Type
11.6.1 X-Ray
11.6.2 Computed Tomography (CT)
11.6.3 Magnetic Resonance Imaging (MRI)
11.6.4 Coronary Angiography
11.6.5 Electrocardiogram (EKG)
11.6.6 Others.
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Cardiac Tamponade Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Cardiac Centers
11.10.4 Academic Institutes
11.10.5 Research Institutes
11.10.6 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Cardiac Tamponade Analysis and Forecast
12.1 Introduction
12.2 Latin America Cardiac Tamponade Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Cardiac Tamponade Market Size Forecast by Type
12.6.1 X-Ray
12.6.2 Computed Tomography (CT)
12.6.3 Magnetic Resonance Imaging (MRI)
12.6.4 Coronary Angiography
12.6.5 Electrocardiogram (EKG)
12.6.6 Others.
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Cardiac Tamponade Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Cardiac Centers
12.10.4 Academic Institutes
12.10.5 Research Institutes
12.10.6 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Cardiac Tamponade Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Cardiac Tamponade Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Cardiac Tamponade Market Size Forecast by Type
13.6.1 X-Ray
13.6.2 Computed Tomography (CT)
13.6.3 Magnetic Resonance Imaging (MRI)
13.6.4 Coronary Angiography
13.6.5 Electrocardiogram (EKG)
13.6.6 Others.
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Cardiac Tamponade Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Cardiac Centers
13.10.4 Academic Institutes
13.10.5 Research Institutes
13.10.6 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cardiac Tamponade Market: Competitive Dashboard
14.2 Global Cardiac Tamponade Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Boston Scientific Corporation
14.3.2 Medtronic
14.3.3 Abbott
14.3.4 Hitachi, Ltd.
14.3.5 Koninklijke Philips N.V.
14.3.6 Siemens AG
14.3.7 Cardio Vascular Services
14.3.8 General Electric
14.3.9 Edwards Lifesciences Corporation
14.3.10 Summit Medical Group
14.3.11 Clinical Care Options, LLC.
14.3.12 High Impact Incorporated
14.3.13 Epic Medical Concepts & Innovations
